A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

10.3802/jgo.2021.32.e31

Saved in:

Bibliographic Details
Main Authors:	Lee, Yong Jae, Lim, Myong Cheol, Kim, Byoung-Gie, Ngoi, Natalie YL, Choi, Chel Hun, Park, Sang-Yoon, Tan, David SP, Go, Yunjung, Lee, Jung-Yun
Other Authors:	DEPT OF MEDICINE
Format:	Article
Published:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/186260
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-186260
record_format	dspace
spelling	sg-nus-scholar.10635-1862602023-09-13T21:35:21Z A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) Lee, Yong Jae Lim, Myong Cheol Kim, Byoung-Gie Ngoi, Natalie YL Choi, Chel Hun Park, Sang-Yoon Tan, David SP Go, Yunjung Lee, Jung-Yun DEPT OF MEDICINE 10.3802/jgo.2021.32.e31 Journal of Gynecologic Oncology 32 2021-02-08T01:24:08Z 2021-02-08T01:24:08Z 2020 2021-02-08T01:10:09Z Article Lee, Yong Jae, Lim, Myong Cheol, Kim, Byoung-Gie, Ngoi, Natalie YL, Choi, Chel Hun, Park, Sang-Yoon, Tan, David SP, Go, Yunjung, Lee, Jung-Yun (2020). A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01). Journal of Gynecologic Oncology 32. ScholarBank@NUS Repository. https://doi.org/10.3802/jgo.2021.32.e31 20050380 20050399 https://scholarbank.nus.edu.sg/handle/10635/186260 Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.3802/jgo.2021.32.e31
author2	DEPT OF MEDICINE
author_facet	DEPT OF MEDICINE Lee, Yong Jae Lim, Myong Cheol Kim, Byoung-Gie Ngoi, Natalie YL Choi, Chel Hun Park, Sang-Yoon Tan, David SP Go, Yunjung Lee, Jung-Yun
format	Article
author	Lee, Yong Jae Lim, Myong Cheol Kim, Byoung-Gie Ngoi, Natalie YL Choi, Chel Hun Park, Sang-Yoon Tan, David SP Go, Yunjung Lee, Jung-Yun
spellingShingle	Lee, Yong Jae Lim, Myong Cheol Kim, Byoung-Gie Ngoi, Natalie YL Choi, Chel Hun Park, Sang-Yoon Tan, David SP Go, Yunjung Lee, Jung-Yun A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
author_sort	Lee, Yong Jae
title	A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
title_short	A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
title_full	A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
title_fullStr	A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
title_full_unstemmed	A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
title_sort	single-arm phase ii study of olaparib maintenance with pembrolizumab and bevacizumab in brca non-mutated patients with platinum-sensitive recurrent ovarian cancer (opeb-01)
publisher	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/186260
_version_	1779153227314364416

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

Similar Items